{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:52:38Z","timestamp":1781927558457,"version":"3.54.5"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,6,15]]},"DOI":"10.2169\/internalmedicine.6263-25","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:07:14Z","timestamp":1762985234000},"page":"1699-1703","source":"Crossref","is-referenced-by-count":0,"title":["Cerebellar-onset Progressive Multifocal Leukoencephalopathy (PML) Associated with Hepatitis B-related Liver Cirrhosis"],"prefix":"10.2169","volume":"65","author":[{"given":"Kota","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Neurology, Brain Attack Center Ota Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brain Attack Center Ota Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brain Attack Center Ota Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Nakamichi","sequence":"additional","affiliation":[{"name":"Department of Virology 1, National Institute of Infectious Diseases, Japan Institute for Health Security, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harutaka","family":"Katano","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Terasawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brain Attack Center Ota Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nakamichi K, Mizusawa H, Yamada M, et al. Characteristics of progressive multifocal leukoencephalopathy clarified through internet-assisted laboratory surveillance in Japan. BMC Neurol 12: 121, 2012.","DOI":"10.1186\/1471-2377-12-121"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yousry TA, Major EO, Ryschkewitsch C, et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 354: 924-933, 2006.","DOI":"10.1056\/NEJMoa054693"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Schwab N, Schneider-Hohendorf T, Melzer N, et al. Natalizumab-associated PML: challenges with incidence, resulting risk, and risk stratification. Neurology 88: 1197-1205, 2017.","DOI":"10.1212\/WNL.0000000000003739"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Berger JR, Cree BA, Greenberg B, et al. Progressive multifocal leukoencephalopathy after fingolimod treatment. Neurology 90: e1815-e1821, 2018.","DOI":"10.1212\/WNL.0000000000005529"},{"key":"5","unstructured":"5. Ali Cherif A, Delpuech F, Habib M, et al. [Progressive multifocal leukoencephalopathy, clinical, CT scan and neuropathologic findings. Apropos of 4 cases] Rev Neurol (Paris) 139: 177-186, 1983 (in French, abstract in English)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Astrom KE, Stoner GL. Early pathological changes in progressive multifocal leukoencephalopathy: a report of two asymptomatic cases occurring prior to the AIDS epidemic. Acta Neuropathol 88: 93-105, 1994.","DOI":"10.1007\/BF00294365"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hoogenraad TU, Jansen GH, Hattum J. Extrahepatic manifestations of hepatitis C virus infection. Ann Intern Med 125: 345; author reply 346, 1996.","DOI":"10.7326\/0003-4819-125-4-199608150-00019"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lima MA, Auriel E, Wuthrich C, et al. Progressive multifocal leukoencephalopathy as a complication of hepatitis C virus treatment in an HIV-negative patient. Clin Infect Dis 41: 417-419, 2005.","DOI":"10.1086\/431769"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Matsuda H, Hayashi K, Meguro M, et al. A case report of progressive multifocal leukoencephalopathy in a human T-cell lymphotropic virus type 1-infected hemodialytic patient. Ther Apher Dial 10: 291-295, 2006.","DOI":"10.1111\/j.1744-9987.2006.00371.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Acket B, Guillaume M, Tardy J, et al. Progressive multifocal leukoencephalopathy in a patient with alcoholic cirrhosis. Gastroenterol Clin Biol 34: 336-338, 2010.","DOI":"10.1016\/j.gcb.2010.02.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gheuens S, Pierone G, Peeters P, et al. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry 81: 247-254, 2010.","DOI":"10.1136\/jnnp.2009.187666"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Almeida AI, Sousa JM, Vedor S, et al. Progressive multifocal leukoencephalopathy presenting with confusion and behavioral disturbances in an HIV-negative patient. Braz J Psychiatry 45: 301-302, 2023.","DOI":"10.47626\/1516-4446-2022-3007"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Auma AWN, Shive CL, Kostadinova L, et al. Variable normalization of na\u00efve CD4+ lymphopenia and markers of monocyte and T cell activation over the course of direct-acting anti-viral treatment of chronic hepatitis C virus infection. Viruses 14: 50, 2021.","DOI":"10.3390\/v14010050"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Leboss\u00e9 F, Gudd C, Tunc E, et al. CD8+T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction. EBioMedicine 49: 258-268, 2019.","DOI":"10.1016\/j.ebiom.2019.10.011"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Maas RP, Muller-Hansma AH, Esselink RA, et al. Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases. J Neurol 263: 2004-2021, 2016.","DOI":"10.1007\/s00415-016-8217-x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sahraian MA, Radue EW, Eshaghi A, et al. Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis. Eur J Neurol 19: 1060-1069, 2012.","DOI":"10.1111\/j.1468-1331.2011.03597.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Aotsuka Y, Uzawa A, Nishimura K, et al. Progressive multifocal leukoencephalopathy localized in the cerebellum and brainstem associated with idiopathic CD4<sup>+<\/sup> T lymphocytopenia. Intern Med 55: 1645-1647, 2016.","DOI":"10.2169\/internalmedicine.55.6649"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shah R, Bag AK, Chpman PR, et al. Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol 65: 431-439, 2010.","DOI":"10.1016\/j.crad.2010.03.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Adra N, Goodheart AE, Rapalino O, et al. MRI shrimp sign in cerebellar progressive multifocal leukoencephalopathy: description and validation of a novel observation. AJNR Am J Neuroradiol 42: 1073-1079, 2021.","DOI":"10.3174\/ajnr.A7145"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ohnuki E, Asayama S, Asayama T, et al. A case of progressive multifocal leukoencephalopathy with chronic renal failure, whose JC virus in cerebrospinal fluid disappeared after mefloquine-mirtazapine dual therapy. Rinsho Shinkeigaku (Clin Neurol) 56: 705-708, 2016 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.cn-000928"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Akagawa Y, Ueno A, Ikeda J, Ishii W, Shishido-Hara Y, Sekijima Y. Two patients with progressive multifocal leukoencephalopathy with immune response against JC virus showing good long-term outcome by combination therapy of mefloquine, mirtazapine, and risperidone. Rinsho Shinkeigaku (Clin Neurol) 58: 324-331, 2018 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.cn-001166"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/12\/65_6263-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:37:26Z","timestamp":1781926646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/12\/65_6263-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6263-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"article-number":"6263-25"}}